{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:34:51Z","timestamp":1790343291618,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jad.2018.09.067","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T22:27:35Z","timestamp":1537223255000},"page":"503-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"special_numbering":"C","title":["A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2716-0712","authenticated-orcid":false,"given":"Kelly","family":"Perlman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Benrimoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-4179","authenticated-orcid":false,"given":"Sonia","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Rollins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingla-Fri","family":"Tunteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Tanguay-Sela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Snook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miresco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo T.","family":"Berlim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2018.09.067_bib0002","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/0269881110388323","article-title":"The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants","volume":"25","author":"Alhaj","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0008","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neubiorev.2013.06.006","article-title":"The role of COMT gene variants in depression: bridging neuropsychological, behavioral and clinical phenotypes","volume":"37","author":"Antypa","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2018.09.067_bib0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1139\/jpn.0243","article-title":"Psychosocial and clinical predictors of response to pharmacotherapy for depression","volume":"27","author":"Bagby","year":"2002","journal-title":"J. Psychiatry Neurosci.: JPN"},{"key":"10.1016\/j.jad.2018.09.067_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2012.01.006","article-title":"Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders","volume":"134","author":"Balaratnasingam","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2018.09.067_bib0012","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/da.22299","article-title":"Toward the application of functional neuroimaging to individualized treatment for anxiety and depression","volume":"31","author":"Ball","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2018.09.067_bib0013","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/npp.2016.169","article-title":"Genetic contributions of inflammation to depression","volume":"42","author":"Barnes","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.09.067_bib0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuropharm.2012.04.021","article-title":"The neurobiology of the EEG biomarker as a predictor of treatment response in depression","volume":"63","author":"Baskaran","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2018.09.067_bib0019","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40263-017-0418-z","article-title":"Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants","volume":"31","author":"Belzeaux","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2018.09.067_bib0022","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/07853890701769728","article-title":"Current trends in the assessment and somatic treatment of resistant\/refractory major depression: an overview","volume":"40","author":"Berlim","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.jad.2018.09.067_bib0023","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0024","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146262","article-title":"Economic evaluations of pharmacogenetic and pharmacogenomic screening tests: a systematic review. second update of the literature","volume":"11","author":"Berm","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2018.09.067_bib0026","doi-asserted-by":"crossref","first-page":"223","DOI":"10.31887\/DCNS.2005.7.3\/bbondy","article-title":"Pharmacogenomics in depression and antidepressants","volume":"7","author":"Bondy","year":"2005","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.09.067_bib0028","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1570159X13666150307004545","article-title":"A review of biomarkers in mood and psychotic disorders: a dissection of clinical vs. preclinical correlates","volume":"13","author":"Brand","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.drudis.2014.02.002","article-title":"Are there meaningful biomarkers of treatment response for depression?","volume":"19","author":"Breitenstein","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jad.2018.09.067_bib0031","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S1092852900001206","article-title":"Predictors of therapeutic response to treatments for depression: a review of electrophysiologic and dichotic listening studies","volume":"4","author":"Bruder","year":"1999","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2018.09.067_bib0033","doi-asserted-by":"crossref","unstructured":"Cannon, D., 2010. Neuroimaging and the Pathophysiology and Treatment of Depression: Recent Advances and Future Needs.","DOI":"10.1159\/000319510"},{"key":"10.1016\/j.jad.2018.09.067_bib0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jad.2015.07.002","article-title":"Imaging predictors of remission to anti-depressant medications in major depressive disorder","volume":"186","author":"Chi","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.09.067_bib0038","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.psychres.2016.04.034","article-title":"Socio-demographic and clinical predictors of non-response\/non-remission in treatment resistant depressed patients: a systematic review","volume":"240","author":"De Carlo","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2018.09.067_bib0039","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2014.09.028","article-title":"A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder","volume":"172","author":"Dichter","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.09.067_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13651500410005423","article-title":"Predictors of antidepressant response: a selective review","volume":"8","author":"Dodd","year":"2004","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2018.09.067_bib0042","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1017\/S1461145711000083","article-title":"A critical review of pharmacotherapy for major depressive disorder","volume":"14","author":"Dupuy","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0043","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1570159X1304150831121909","article-title":"Brain structural effects of antidepressant treatment in major depression","volume":"13","author":"Dusi","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0044","doi-asserted-by":"crossref","first-page":"191","DOI":"10.31887\/DCNS.2006.8.2\/fduval","article-title":"Treatments in depression","volume":"8","author":"Duval","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.09.067_bib0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fphar.2013.00146","article-title":"Mechanisms of antidepressant resistance","volume":"4","author":"El-Hage","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0046","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0193-953X(02)00104-1","article-title":"Predictors of response in depression","volume":"26","author":"Esposito","year":"2003","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2018.09.067_bib0047","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10401230500464661","article-title":"Using neuroimaging to predict treatment response in mood and anxiety disorders","volume":"18","author":"Evans","year":"2006","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0051","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/15622975.2016.1208843","article-title":"Consensus paper of the WFSBP task force on genetics: genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response","volume":"18","author":"Fabbri","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0052","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/070674371405900202","article-title":"From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment","volume":"59","author":"Fabbri","year":"2014","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0053","doi-asserted-by":"crossref","unstructured":"Farace, D.J., Sch\u00f4pfel, J., 2010. Grey Literature in Library and Information Studies.","DOI":"10.1515\/9783598441493"},{"key":"10.1016\/j.jad.2018.09.067_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001547","article-title":"Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010","volume":"10","author":"Ferrari","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2018.09.067_bib0059","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neubiorev.2017.10.012","article-title":"Hypothalamic-pituitary-adrenal (HPA) axis functioning as predictor of antidepressant response\u2013meta-analysis","volume":"83","author":"Fischer","year":"2017","journal-title":"Neurosc. Biobehav. Rev."},{"key":"10.1016\/j.jad.2018.09.067_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145713000746","article-title":"Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials","volume":"17","author":"Gibiino","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0067","series-title":"Deep Learning","author":"Goodfellow","year":"2016"},{"key":"10.1016\/j.jad.2018.09.067_bib0068","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1258\/mi.2009.009021","article-title":"Depression and the menopause: why antidepressants are not enough?","volume":"15","author":"Graziottin","year":"2009","journal-title":"Menopause Int."},{"key":"10.1016\/j.jad.2018.09.067_bib0069","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br. J. Soc. Clin. Psychol."},{"key":"10.1016\/j.jad.2018.09.067_bib0071","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.3390\/ijms16047796","article-title":"Inflammatory biomarkers as differential predictors of antidepressant response","volume":"16","author":"Hashimoto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2018.09.067_bib0073","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0327(00)00353-0","article-title":"Event-related potentials: do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?","volume":"62","author":"Hegerl","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.09.067_bib0075","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jad.2018.09.067_bib0077","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2009.06.007","article-title":"Pharmacogenomics of antidepressant drugs","volume":"124","author":"Horstmann","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2018.09.067_bib0078","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10673229.2011.586550","article-title":"Glucocorticoids as predictors of treatment response in depression","volume":"19","author":"Horstmann","year":"2011","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jpsychores.2009.11.009","article-title":"Negative association of concomitant physical symptoms with the course of major depressive disorder: a systematic review","volume":"68","author":"Huijbregts","year":"2010","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jad.2018.09.067_bib0081","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psc.2006.12.002","article-title":"The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder","volume":"30","author":"Hunter","year":"2007","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2018.09.067_bib0083","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1755-5949.2008.00063.x","article-title":"Prediction of response to antidepressants: is quantitative EEG (QEEG) an alternative?","volume":"14","author":"Iosifescu","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jad.2018.09.067_bib0084","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/10673229.2011.586549","article-title":"Electroencephalography-derived biomarkers of antidepressant response","volume":"19","author":"Iosifescu","year":"2011","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11920-004-0064-2","article-title":"Impact of medical comorbid disease on antidepressant treatment of major depressive disorder","volume":"6","author":"Iosifescu","year":"2004","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2018.09.067_bib0086","unstructured":"Iosifescu, D.V., Lapidus, K., 2011. The role of neuroimaging and electrophysiology (EEG) as predictors of treatment response in major depressive disorder."},{"key":"10.1016\/j.jad.2018.09.067_bib0087","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.pnpbp.2005.03.014","article-title":"The combined dexamethasone\/CRH test as a potential surrogate marker in depression","volume":"29","author":"Ising","year":"2005","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0089","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fnhum.2015.00018","article-title":"Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers","volume":"9","author":"Jani","year":"2015","journal-title":"Front. Human Neurosci."},{"key":"10.1016\/j.jad.2018.09.067_bib0091","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/ije\/dyu273","article-title":"Epigenetics and depressive disorders: a review of current progress and future directions","volume":"44","author":"Januar","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jad.2018.09.067_bib0097","doi-asserted-by":"crossref","unstructured":"Keers, R., 2012. Will gene-environment interactions explain differential antidepressant response?","DOI":"10.2217\/pme.12.28"},{"key":"10.1016\/j.jad.2018.09.067_bib0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11920-011-0251-x","article-title":"Gene-environment interaction in major depression and antidepressant treatment response","volume":"14","author":"Keers","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2018.09.067_bib0101","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1017\/S1092852900017120","article-title":"Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures","volume":"13","author":"Kemp","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2018.09.067_bib0102","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0104","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.09.067_bib0108","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/jnnp-2011-301779","article-title":"Depression: an inflammatory illness?","volume":"83","author":"Krishnadas","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0109","doi-asserted-by":"crossref","unstructured":"Krishnan, K.R.R., 2003. Comorbidity and depression treatment.","DOI":"10.1016\/S0006-3223(02)01787-0"},{"key":"10.1016\/j.jad.2018.09.067_bib0110","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1377\/hlthaff.2014.0053","article-title":"Big data and new knowledge in medicine: the thinking, training, and tools needed for a learning health system","volume":"33","author":"Krumholz","year":"2014","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.jad.2018.09.067_bib0113","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2013\/984845","article-title":"Biomarkers predicting antidepressant treatment response: how can we advance the field?","volume":"35","author":"Labermaier","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jad.2018.09.067_bib0115","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0706743716659416","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical guidelines for the management of adults with major depressive disorder: section 1. disease burden and principles of care","volume":"61","author":"Lam","year":"2016","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/nyas.12759","article-title":"In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature","volume":"1344","author":"Lener","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2018.09.067_bib0120","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40263-016-0385-9","article-title":"Pharmacogenetics and imaging-pharmacogenetics of antidepressant response: towards translational strategies","volume":"30","author":"Lett","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2018.09.067_bib0121","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11920-010-0160-4","article-title":"Biomarkers to predict antidepressant response","volume":"12","author":"Leuchter","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2018.09.067_bib0122","doi-asserted-by":"crossref","first-page":"435","DOI":"10.31887\/DCNS.2009.11.4\/afleuchter","article-title":"A new paradigm for the prediction of antidepressant treatment response","volume":"11","author":"Leuchter","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.09.067_bib0129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/B978-0-12-800977-2.00005-X","article-title":"Epigenetics of depression","volume":"128","author":"Lolak","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jad.2018.09.067_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.2013.733696","article-title":"What is the role of pharmacogenetics in clinical psychiatry?","volume":"9","author":"Lombard","year":"2013","journal-title":"Expert Opinion Drug Metabol. Toxicol."},{"key":"10.1016\/j.jad.2018.09.067_bib0131","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.09.017","article-title":"A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers","volume":"48","author":"Lopresti","year":"2014","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0134","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1139\/jpn.0945","article-title":"Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder","volume":"34","author":"MacQueen","year":"2009","journal-title":"J. Psychiatry Neurosci.: JPN"},{"key":"10.1016\/j.jad.2018.09.067_bib0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/09540261.2013.825580","article-title":"Gene expression: biomarker of antidepressant therapy?","volume":"25","author":"Menke","year":"2013","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0143","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0144","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1176\/appi.ajp.159.3.359","article-title":"Personality pathology and treatment outcome in major depression: a review","volume":"159","author":"Mulder","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.jad.2018.09.067_bib0138","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.9104su1c.03","article-title":"When should you move beyond first-line therapy for depression?","volume":"71","author":"McIntyre","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0146","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/pgs.12.1","article-title":"Pharmacogenetics of antidepressant drugs: current clinical practice and future directions","volume":"13","author":"Narasimhan","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jad.2018.09.067_bib0149","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1192\/bjp.188.1.13","article-title":"Personality disorder and the outcome of depression: meta-analysis of published studies","volume":"188","author":"Newton-Howes","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0150","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0193-953X(02)00105-3","article-title":"Predictors of response to antidepressants general principles and clinical implications","volume":"26","author":"Nierenberg","year":"2003","journal-title":"Psychiatr. Clin. North Am."},{"issue":"Suppl 16","key":"10.1016\/j.jad.2018.09.067_bib0151","first-page":"5","article-title":"Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression","volume":"62","author":"Nierenberg","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl E1","key":"10.1016\/j.jad.2018.09.067_bib0153","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0154","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hup.940","article-title":"The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings","volume":"23","author":"O'Neill","year":"2008","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0157","doi-asserted-by":"crossref","first-page":"439","DOI":"10.31887\/DCNS.2008.10.4\/gipapakostas","article-title":"Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder","volume":"10","author":"Papakostas","year":"2008","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.09.067_bib0158","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0924-977X(03)00099-3","article-title":"Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses","volume":"14","author":"Papakostas","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0159","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychires.2007.05.012","article-title":"Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials","volume":"42","author":"Papakostas","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.09.067_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0000000000000024","article-title":"Melancholia: definition and management","volume":"27","author":"Parker","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0161","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jad.2015.12.066","article-title":"Identifying a clinical signature of suicidality among patients with mood disorders: a pilot study using a machine learning approach","volume":"193","author":"Passos","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.09.067_bib0163","first-page":"323","article-title":"Biological predictors of treatment response in affective illness","volume":"26","author":"Perlis","year":"2003","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.jad.2018.09.067_bib0164","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1176\/appi.ajp.2014.14010076","article-title":"Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches","volume":"172","author":"Phillips","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0167","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/npp.2010.166","article-title":"Frontocingulate dysfunction in depression: toward biomarkers of treatment response","volume":"36","author":"Pizzagalli","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.09.067_bib0174","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1515\/dmpt-2016-0019","article-title":"Pharmacogenetic studies: a tool to improve antidepressant therapy","volume":"31","author":"Ramos","year":"2016","journal-title":"Drug Metabol. Pers. Ther."},{"key":"10.1016\/j.jad.2018.09.067_bib0175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/da.20251","article-title":"Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils","volume":"24","author":"Rasmussen-Torvik","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2018.09.067_bib0177","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cll.2016.05.008","article-title":"Clinical utility and economic impact of CYP2D6 genotyping","volume":"36","author":"Reynolds","year":"2016","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.jad.2018.09.067_bib0179","doi-asserted-by":"crossref","unstructured":"Roiser, J., Sahakian, B., 2013. Hot and cold cognition in depression.","DOI":"10.1017\/S1092852913000072"},{"key":"10.1016\/j.jad.2018.09.067_bib0180","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0183","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/mp.2013.25","article-title":"Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play","volume":"18","author":"Savitz","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00001504-200411000-00005","article-title":"Neuroimaging in old age psychiatry","volume":"17","author":"Scheltens","year":"2004","journal-title":"Curr. Opinion Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0187","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/1570159X14666160115130414","article-title":"Inflammation and immune regulation as potential drug targets in antidepressant treatment","volume":"14","author":"Schmidt","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2018.09.067_bib0188","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/npp.2011.151","article-title":"Functional biomarkers of depression: diagnosis, treatment, and pathophysiology","volume":"36","author":"Schmidt","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2018.09.067_bib0305","doi-asserted-by":"crossref","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"for the CONSORT Group. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jad.2018.09.067_bib0192","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/da.20831","article-title":"What little we know about tailoring depression treatment for individual patients","volume":"28","author":"Simon","year":"2011","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2018.09.067_bib0193","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1176\/appi.ajp.2010.09111680","article-title":"Personalized medicine for depression: can we match patients with treatments?","volume":"167","author":"Simon","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0198","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpsychires.2009.08.013","article-title":"Wake and sleep EEG provide biomarkers in depression","volume":"44","author":"Steiger","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.09.067_bib0199","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1176\/jnp.9.2.208","article-title":"Recurrence and relapse in geriatric depression: a review of risk factors and prophylactic treatment strategies","volume":"9","author":"Stoudemire","year":"1997","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.09.067_bib0201","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2147\/NDT.S114542","article-title":"Biomarkers for depression: recent insights, current challenges and future prospects","volume":"13","author":"Strawbridge","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2018.09.067_bib0203","doi-asserted-by":"crossref","first-page":"539","DOI":"10.31887\/DCNS.2014.16.4\/mthase","article-title":"Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies","volume":"16","author":"Thase","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"issue":"Suppl 4","key":"10.1016\/j.jad.2018.09.067_bib0204","first-page":"27","article-title":"Clinical significance of monitoring early symptom change to predict outcome","volume":"62","author":"Trivedi","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1875692110806020126","article-title":"Effect of Brain-Derived Neurotrophic Factor (BDNF) gene variants on the therapeutic response and the risk for mood disorders","volume":"6","author":"Tsai","year":"2008","journal-title":"Curr. Pharmacogenomics Pers. Med. (Formerly Current Pharmacogenomics)"},{"key":"10.1016\/j.jad.2018.09.067_bib0206","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/mp.2008.92","article-title":"The implications of gene-environment interactions in depression: will cause inform cure?","volume":"13","author":"Uher","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0207","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10673229.2011.586551","article-title":"Genes, environment, and individual differences in responding to treatment for depression","volume":"19","author":"Uher","year":"2011","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0209","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10673220802277938","article-title":"Predicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic review","volume":"16","author":"Van","year":"2008","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0212","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11920-007-0061-3","article-title":"The STAR*D Project results: a comprehensive review of findings","volume":"9","author":"Warden","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2018.09.067_bib0213","first-page":"87","article-title":"Pharmacogenetics of antidepressive drugs: a way towards personalized treatment of major depressive disorder","volume":"14","author":"Weizman","year":"2012","journal-title":"Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja\u202f=\u202fofficial journal of the Hungarian Association of Psychopharmacology"},{"key":"10.1016\/j.jad.2018.09.067_bib0214","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174944","article-title":"Can machine-learning improve cardiovascular risk prediction using routine clinical data?","volume":"12","author":"Weng","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jad.2018.09.067_bib0216","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3109\/09540261.2013.812067","article-title":"Sleep as a biomarker for depression","volume":"25","author":"Wichniak","year":"2013","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.pnpbp.2004.01.008","article-title":"Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review","volume":"28","author":"Yoshimura","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0221","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fpsyt.2016.00072","article-title":"Is there progress? An overview of selecting biomarker candidates for major depressive disorder","volume":"7","author":"Young","year":"2016","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2018.09.067_bib0222","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/pgs.14.40","article-title":"Towards a personalized treatment in depression: endocannabinoids, inflammation and stress response","volume":"15","author":"Zajkowska","year":"2014","journal-title":"Pharmacogenomics"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718309947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718309947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:21:06Z","timestamp":1759022466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718309947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":115,"alternative-id":["S0165032718309947"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2018.09.067","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2018.09.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}